POCHIRAJU

Pochiraju Industries Limited has informed the Exchange regarding Board meeting held on February 12, 2021.

Pochiraju Industries Limited has informed the Exchange regarding Board meeting held on February 14, 2020.

Pochiraju Industries Limited has informed the Exchange regarding Board meeting held on November 14, 2019.

Pochiraju Industries Limited has informed the Exchange regarding Board meeting held on August 14, 2019.

Pochiraju Industries Limited has informed the Exchange regarding Board meeting held on February 14, 2019.

Pochiraju Industries Limited has informed the Exchange regarding Board meeting held on November 14, 2018.

Pochiraju Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2018.

Pochiraju Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on May 29, 2018.

Pochiraju Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on February 14, 2018.

Pochiraju Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on November 14, 2017.

Pochiraju Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on September 14, 2017.

Pochiraju Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on May 29, 2017.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 12, 2016 has : (1) As the company's bankers PNB initiated action under SARFAESI Act and issued public auction of the Company's properties the operations of the Company are still under closure.(2) The Management of the company is exploring various options to revive the operations of the Company.

Pochiraju Industries Limited has inform the exchange regarding the outcome of the Meeting Board of Directors held on May 28, 2016.

Pochiraju Industries Limited has informed the Exchange that the outcome of the board meeting of the company held on February 13, 2016 is as follows: (1) the Management of the company is in the process of discussions negotiations with bankers/ interested parties to work out a solution for the revival of the company.

Pochiraju Industries Limited has informed the Exchange that the outcome of the board meeting of the company held on November 12, 2015 is as follows :1. The Board has reviewed the progress of the Agri Division, Bio Pharma Division and Pharma Divisions of the company. The operations of both the divisions are going slow due to the financial constraints the company is going presently and also due to the the recovery proceedings undertaken by PNB.

Pochiraju Industries Limited has informed the Exchange regarding Outcome of Board Meeting held August 10, 2015.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 28, 2015, has reviewed the progress of the Agri Division, Bio Pharma Division and Pharma Divisions of the Company.

Pochiraju Industries Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on February 14, 2015.

Pochiraju Industries Limited has informed the Exchange that the outcome of the board meeting of the company held on November 13, 2014 is as follows: 1. The Board has reviewed the progress of the Agri, Bio and Pharma Divisions of the company. 2. Reviewed the Phase II expansion of Bio Pharma Unit and considered various funding options Viz ..Raising of Debt, Preferential AIIotment of Equity Shares and Preferential Allotment of Warrants to promoters. Board approved for completing the Phase II expansion raising resources upto Rs.150.00 crores by way of Debt/ Preferential allotment of shares / al

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the company at its meeting held on August 14, 2014 has reviewed the progress of the Agri, Bio and Pharma Division of the company.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 24, 2014,has reviewed the progress of Bio-pharm and Pharma Division.

Pochiraju Industries Limited has informed the Exchange regarding the outcome of the Board Meeting of the Company held on August 14, 2013, which is as follows: 1. The Annual General Meeting of the Company will be held on September 26, 2013 at the Registered Office of the Company. 2. The Board has reviewed the progress of the Agri, Bio and Pharma divisions of the Company.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on May 29, 2013 have reviewed the progress of Bio-Pharma and Pharma Division.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 12, 2012, reviewed the progress of Bio-Pharma and Pharma Division.

Pochiraju Industries Limited has informed the Exchange that the Outcome of the meeting of the Board of Directors of the Company held on August 27, 2012 is as follows : (1) The Board has approved the audited financial results of the company for the year ended March 31, 2012, Directors' report; (2) The Board has recommended for appointment of Sri.P.Sudhakar as Managing Director of the company for a further period of 5 years.

Pochiraju Industries Limited has informed the Exchange regarding the Outcome of the Board Meeting of the Company held on May 12, 2012.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 29, 2012, has transacted the following : (1) The Board noted that the Share Warrants which were allotted on July 29, 2010 liable to be converted within 18 months i.e., on or before January 29, 2012. As the period of 18 months elapsed from the date of allotment the Board decided not to convert any outstanding Share Warrants into equity; (2)Reviewed the progress of Bio-Pharma and Pharma Division.

Pochiraju Industries Limited has informed the Exchange regarding the Outcome of the Board Meeting of the Company held on January 25, 2012 which: (1) Reviewed the progress of Bio-Pharma and Pharma Division.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 31, 2011, inter alia, has approved the following: (1)Reviewed the progress of (a) Agri Division; (b) Pharmacy Division; (c) Biotech Division; (2) The appointment of whole time Company secretary; (3) Passed a resolution for shifting of Admin office from 202, SGC's Suresh Arcade, Opp. Nature Cure Hospitals, Dharma Karam Road, Ameerpet, Hyderabad-500016 to Administrative Block of Biotech Plant at Plot No.7, Phase-II, S. P. Bio-Tech Park, Shameerpet, Ranga Reddy District

Pochiraju Industries Limited has informed the Exchange that the outcome of the board meeting of the Company held on March 29, 2011 is as follows : (1) The Board has duly considered and allotted 10,00,000 Equity shares of Rs. 10/- each with a premium of Rs. 10.10/- upon conversion of 10,00,000 warrants to the promoters on preferential basis; (2)The Board has expressed its condolences for the sudden demise of Smt. P. Bala Tripura Sundari, Director of the company on February 10, 2011; (3) Reviewed the progress of Bio-Pharma, Pharma and Agri Divisions.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors at its meeting held on July 28, 2010 has (1) Reviewed the progress of Bio-Pharma, Pharma and Divisions (2) The Board has allotted 40,00,000 (Forty Lakhs only) warrants to Sri. P. Sudhakar, Promoter of the company at Rs. 10 each per share at a premium of Rs. 10.15 each as per guidelines of SEBI in this regard.

Pochiraju Industries Limited has informed the Exchange that the Board of Directors at its meeting held on April 28, 2010 has :- (1) Reviewed the progress of Bio-Pharma and Pharma Division; (2) As the F & V division of the company is having good potential and is growing the Board has decided to expand the same by creating agri infrastructure facilities and logistics at potential distribution and consumption centers.

Pochiraju Industries Limited has informed the Exchange that the outcome of the Board meeting of the Company held on January 29, 2010 is as follows: (1) Reviewed the progress of Bio-Pharma and Pharma Division. (2) The Board has approved to raise funds for the on going expansion of the state of the art Bio-Pharma unit at Shameerpet, Bulk API plant at APIIC industrial estate, Nadikudi, Guntur Dist., A.P., and the Fruits & Vegetables division. (3) For this expansion plans it was decided by the Board to issue 40,00,000 convertible share warrants to the promoters on preferential basis at a price to

Pochiraju Industries Limited has informed the Exchange that the outcome of the board meeting of the Company held on October 29, 2009 is as follows: (1) Reviewed the progress of Bio-Pharma and Pharma Division. (2) The Board also discussed the progress of on going R&D projects for process development of Bio-Similars more particularly combination vaccines and latest Onocology products.

Pochiraju Industries Limited has informed the Exchange regarding the outcome of the board meeting of the Company held on August 26, 2009 is as follows: The Board has held an extensive discussion on the proposal of raising funds and it was decided to do so at the appropriate time. Accordingly the necessary actions will be taken.

Pochiraju Industries Limited has informed the Exchange regarding the outcome of board meeting of the company held on July 28, 2009 is as follows : 1) Reviewed the progress of Bio-Pharma and Pharma Division. 2) The Board has held extensive discussion on the progress of setting up of R&D centre in new process and formulation development.

Pochiraju Industries Limited has informed the Exchange that the board meeting of the Company held on April 27, 2009 is as follows: (1) Reviewed the progress of Bio-Pharma and Pharma Division. (2) The Board has approved to setup a bulk API plant at APIIC Industrial Estate Nadikudi, Guntur Dist- AP. (3) The Board also discussed the necessity of having R & D activities in new process and formulation development and approved setting up of a R & D centre.

Pochiraju Industries Limited has informed the Exchange that the outcome of the board meeting of the Company held on January 29, 2009 is as follows: 1) Reviewed the progress of Bio-Pharma and Pharma Division. 2) The Board has approved launching of Oncology Products in March 2009.

Pochiraju Industries Limited has informed the Exchange that the outcome of the Board Meeting of the Company held on October 27, 2008 is as follows: 1) Reviewed the progress of Bio-Pharma and Pharma Division. 2) The Board has taken on record the extension of Scheme of implementation of Bio Pharma division by about one year.

Pochiraju Industries Limited has informed the Exchange regarding outcome of the Board Meeting of the Company held on April 04, 2008 as follows : (1) The board has reviewed the performance of Pharma Division and Agri business and the progress of Bio Pharma division.

Pochiraju Industries Limited has informed the Exchange regarding the outcome of the Board Meeting of the company held on April 04, 2008 that the board approved the proposed launching of Oncology products in Biopil division in the first quarter of 2008-09.

Pochiraju Industries Limited has informed the Exchange regarding the outcome of the Board Meeting of the company held on January 30, 2008 which is as follows : 1) The board has reviewed the performance of Pharma Division and Agri business and the progress of Bio Pharma division. The proposed launching of the Pharma formulations in five more states of Maharashtra, Kerala, Gujarat, Madhya Pradesh and Chattisgarh was approved by the Board. 2) The Board approved the proposed outsourcing of Bio Pharma products such as EPO, GCSF, Growth harmone and factor 8 & 9 to the Korean Company and launching of

Pochiraju Industries Limited has informed the Exchange regarding the outcome of the Board Meeting of the company held on October 31, 2007 is as follows : 1) The Board has reviewed the launch of Pharma Division in five states of Andhra Pradesh, West Bengal, Orissa, Karnataka and Tamilnadu with a marketing field force of 116 executives. It has taken a decision to launch its speciality division also by end December 2007 with an additional field force of around 90. 2) The progress of the Bio Pharma and Pharma divisions was reviewed by Board. The Board has taken the decision to market Bio Pharma fo